GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Cardamyst® | MSP-2017 | MSP2017
etripamil is an approved drug
Compound class:
Synthetic organic
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. US FDA (2025) |
IUPAC Name ![]() |
| methyl 3-[2-[[(4S)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]-methylamino]ethyl]benzoate |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 10134 | etripamil |
Synonyms ![]() |
| Cardamyst® | MSP-2017 | MSP2017 |
Database Links ![]() |
|
| CAS Registry No. | 1593673-23-4 (source: WHO INN record) |
| ChEMBL Ligand | CHEMBL3707312 |
| DrugBank Ligand | DB12605 |
| PubChem CID | 91824132 |
| Search Google for chemical match using the InChIKey | VAZNEHLGJGSQEL-MHZLTWQESA-N |
| Search Google for chemicals with the same backbone | VAZNEHLGJGSQEL |
| Search PubMed clinical trials | etripamil |
| Search PubMed titles | etripamil |
| Search PubMed titles/abstracts | etripamil |
| UniChem Compound Search for chemical match using the InChIKey | VAZNEHLGJGSQEL-MHZLTWQESA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | VAZNEHLGJGSQEL-MHZLTWQESA-N |